Prosus Marks Significant Markdown For Byju’s And PharmEasy By $3 Billion And $118 Million Respectively
Prosus, a prominent global technology investment firm, has recently marked down the valuations of two major companies in its portfolio,…Read More »
PharmEasy’s Big Decision: Getting Ready to Raise a Huge 73,500 Crore via Rights Issue Next Week PharmEasy, a well-known company…Read More »
Ambitious Expansion: PharmEasy Aims for Rs 3,500 Crore Investment Through Right Issue Amidst the current challenging market conditions, API Holdings…Read More »
‘It’s the end’: Former BharatPe cofounder Ashneer Grover critiques PharmEasy’s plan to raise $300 million
‘It’s the end’: Former BharatPe cofounder Ashneer Grover critiques PharmEasy’s plan to raise $300 million Former BharatPe cofounder Ashneer Grover…Read More »
PharmEasy’s Right Issue to Raise INR 2,400 Crore at a 90% Discount PharmEasy’s decision to raise funds through a rights…Read More »
Salaries and Losses of Unicorns A report’s analysis of 74 Indian unicorns found that 55 (or 74%) had combined operational…Read More »
Slash On Growth For The Sake Of Profit: Is This PharmEasy Move Will Be Easy To Attain Trade-Off Sustainability?
PharmEasy, a health tech startup, appears to be able to keep its head above water. The unicorn, dealing with sluggish…Read More »
The Covenant Violation Unicorn e-pharmacy, within a year of receiving expensive loans from the US-based lender Goldman Sachs, PharmEasy is…Read More »
Why Are Investors Slashing Their Valuations In Indian Start-Ups? Is It A Sign That Founders Need To Think About The Actual Content Of Their Operations Rather Than Focussing On Vanity Matrices?
It has been halfway to the third year of this new decade. Let’s have a look at the entrepreneur circle…Read More »
Janus Henderson, the global investment management firm, has reduced the value of Indian online pharmacy PharmEasy to $2.7 billion. Second,…Read More »